News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces

Aging

September 22, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 17, entitled, “Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces.” continue reading »

Oncotarget | Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy

News

September 20, 2022
PRESS RELEASE: A new Oncotarget research paper was published, entitled, “Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.” continue reading »

Aging | Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study

Aging

September 15, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 17, entitled, “Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study.” continue reading »

Oncotarget | An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside

News

September 15, 2022
PRESS RELEASE: A new editorial paper was published in Oncotarget on September 8, 2022, entitled, “An ABC transporter as a potential target against SHH-Medulloblastoma: From Benchtop to Bedside.” continue reading »

Oncoscience | As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

Oncoscience

September 12, 2022
PRESS RELEASE: Dr. Blagosklonny published a new research commentary in Oncoscience, entitled, “As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression.” continue reading »